We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$557M
AUM Growth
+$8.06M
Cap. Flow
-$17.4M
Cap. Flow %
-3.12%
Top 10 Hldgs %
15.98%
Holding
514
New
65
Increased
139
Reduced
63
Closed
62

Top Buys

Rank Stock Value
1
OVID icon
Ovid Therapeutics
OVID
+$3.98M
2
AMRX icon
Amneal Pharmaceuticals
AMRX
+$2.56M
3
SIGA icon
SIGA Technologies
SIGA
+$2.52M
4
III icon
Information Services Group
III
+$1.69M
5
RVI
Retail Value Inc. Common Shares
RVI
+$1.67M

Top Sells

Rank Stock Value
1
ACH
Accendra Health
ACH
+$5.72M
2
UCTT
Ultra Clean Holdings
UCTT
+$2.82M
3
MITK icon
Mitek Systems
MITK
+$2.11M
4
BLDR icon
Builders FirstSource
BLDR
+$2.1M
5
MEDP icon
Medpace
MEDP
+$2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.86%
2 Industrials 16.1%
3 Technology 15.87%
4 Financials 14.48%
5 Consumer Discretionary 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
426
AbbVie
ABBV
$465B
$9K ﹤0.01%
82
– –
ORCL icon
427
Oracle
ORCL
$339B
$9K ﹤0.01%
118
– –
ELV icon
428
Elevance Health
ELV
$81.5B
$7K ﹤0.01%
18
– –
GILD icon
429
Gilead Sciences
GILD
$165B
$7K ﹤0.01%
95
– –
GOOGL icon
430
Alphabet (Google) Class A
GOOGL
$4.12T
$7K ﹤0.01%
60
– –
AMAT icon
431
Applied Materials
AMAT
$347B
$6K ﹤0.01%
39
– –
MRK icon
432
Merck
MRK
$322B
$6K ﹤0.01%
76
-4
-5% -$298
VZ icon
433
Verizon
VZ
$197B
$6K ﹤0.01%
106
– –
JNJ icon
434
Johnson & Johnson
JNJ
$640B
$5K ﹤0.01%
33
– –
EW icon
435
Edwards Lifesciences
EW
$49.4B
$3K ﹤0.01%
27
– –
HOLX
436
DELISTED
Hologic
HOLX
$3K ﹤0.01%
49
-4,083
-99% -$273K
INTU icon
437
Intuit
INTU
$91.1B
$3K ﹤0.01%
6
– –
MS icon
438
Morgan Stanley
MS
$319B
$3K ﹤0.01%
36
– –
UPS icon
439
United Parcel Service
UPS
$88.9B
$3K ﹤0.01%
16
– –
ZTS icon
440
Zoetis
ZTS
$32.7B
$3K ﹤0.01%
15
– –
ACN icon
441
Accenture
ACN
$106B
$2K ﹤0.01%
8
– –
BMY icon
442
Bristol-Myers Squibb
BMY
$129B
$2K ﹤0.01%
33
– –
CIEN icon
443
Ciena
CIEN
$46.8B
$2K ﹤0.01%
28
– –
F icon
444
Ford
F
$60.9B
$2K ﹤0.01%
159
-33,910
-100% -$451K
IVZ icon
445
Invesco
IVZ
$12.4B
$2K ﹤0.01%
75
– –
LXP icon
446
LXP Industrial Trust
LXP
$3.52B
$2K ﹤0.01%
33
– –
NOC icon
447
Northrop Grumman
NOC
$76B
$2K ﹤0.01%
5
– –
CERN
448
DELISTED
Cerner Corp
CERN
$2K ﹤0.01%
21
-1,905
-99% -$147K
C icon
449
Citigroup
C
$213B
$1K ﹤0.01%
+21
New +$1.55K
HCA icon
450
HCA Healthcare
HCA
$90.6B
$1K ﹤0.01%
+7
New +$1.43K
16 17
18
19 20

Similar funds

RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Globeflex Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Globeflex Capital held 514 positions worth $557M, up 1.5% from $549M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Globeflex Capital withdrew a net $17.4M in Q2 2021, closing 62 positions and reducing 63 holdings. Its most notable exit was Perficient Inc, an estimated $1.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Globeflex Capital opened a new position in Ovid Therapeutics worth $3.95M.

  • Globeflex Capital's largest Q2 2021 buy was Ovid Therapeutics: 1,009,125 shares worth $3.95M.
  • Globeflex Capital added most to Amneal Pharmaceuticals in Q2 2021, an estimated $2.56M increase.
  • Globeflex Capital's biggest Q2 2021 reduction was Accendra Health, cutting an estimated $5.72M.
  • Globeflex Capital fully exited Perficient Inc in Q2 2021, selling an estimated $1.89M.
  • Globeflex Capital's ten largest holdings make up 16% of its $557M portfolio in Q2 2021.
  • Globeflex Capital opened 65 new positions and closed 62 in Q2 2021.
  • Globeflex Capital's portfolio value rose 1.5% quarter-over-quarter to $557M.

Based on Globeflex Capital's 13F filing for Q2 2021, filed 12 Aug 2021.